HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: EU risk materials

This article was originally published in The Rose Sheet

Executive Summary

EU risk materials: Standing Veterinary Committee (DG 6) fails to vote on proposals derogating cosmetics, pharmaceuticals and medical devices from the European Union ban on use of all transmissible spongiform encephalopathies specified risk materials (SRM) set to take effect Jan. 1. The committee met Dec. 8-9 to discuss a series of proposals amending the ban, which is intended to protect the EU from exposure to TSE contaminated animals and animal products, such as cattle with "mad cow" disease ("The Rose Sheet" Dec. 8, p. 10). According to the European Cosmetic, Toiletry and Perfumery Association, the committee could not muster enough votes to get a derogation passed. A decision was reached between DG 6 and the Scientific Steering Committee of the European Community on the definition on SRM; the term "embraces" three concepts -- the species, age and specific organs of an animal...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel